key: cord-0746809-1lxr8tsy authors: Mori, Hideki; Tack, Jan; Suzuki, Hidekazu title: Statements for conducting high-resolution manometry during the COVID-19 pandemic date: 2020-08-22 journal: J Clin Biochem Nutr DOI: 10.3164/jcbn.20-97 sha: 84f142a0e507f3e01288fc3b97591ed0fc9e45b8 doc_id: 746809 cord_uid: 1lxr8tsy To ensure the safety of medical personnel is important during the new coronavirus infectious disease (COVID-19) pandemic. Although high-resolution manometry (HRM) is an essential device for diagnosis of functional gastrointestinal disorders, it contains risks of droplet infection, contact infection and aerosol-borne infection. Screening tests such as PCR, serology test to detect COVID-19 antibodies, and CT scan should be considered as well as body temperature check and anamnestic risk assessment. Moreover, the provision of protective equipment such as a mask with face shield (or goggles + mask), gloves, cap or hairnet, and a long-sleeved gown would be necessary to reduce the risk of COVID-19. Introduction I n the pandemic phase following the spread of the new coronavirus infectious disease , in Japan, as in US or EU, emergency declarations have been issued nationwide, and the Japanese Society of Gastroenterology (JSGE) and Japan Gastroenterological Endoscopy Society (JGES) recommend postponement of non-emergency endoscopy from the perspective of protecting endoscopists and patients. Similar policies should be followed for high-resolution manometry (HRM) that is considered to have the same risk of infection as endoscopy. However, in the early recovery phase, there is a demand for recommending HRM, in consideration of the safety of medical staff and patients. (1) (2) (3) (4) Based on the available evidence, we are proposing the following statements regarding HRM in consideration of the current situation of COVID-19. The infection routes of coronavirus are basically droplet infection and contact infection, the same applies to SARS-CoV-2. (5) Positioning of HRM catheters for gastrointestinal motility tests may also elicit cough or sneezing in patients and hence carries a concern for aerosol-borne infection of health care workers. (6, 7) A high frequency of transmission of the virus by aerosol is likely when subjects are exposed to a high concentration of contaminated aerosol in a closed space such as an examination room for a certain period of time. In addition, HRM catheters can become contaminated with body fluids, so care must be taken when these are handled to avoid infection. Motility disorders of the gastrointestinal tract are generally chronic, and rarely can be considered urgent. We therefore suggest to postpone HRM tests in cases with confirmed or clinically suspected COVID-19, until the (suspected) infection has subsided (Table 1) . (8) (9) (10) (11) (12) If subjects have a history of close contact with COVID-19 patients or have a travel history to an outbreak area within the past 2 weeks, HRM tests should also be postponed. Since there is a risk that also asymptomatic COVID-19 patients can spread the infection, it is recommended to perform HRM tests using the strict criteria listed in Table 2 in the early recovery phase of the COVID-19 epidemic situation. (13) In other words, it is necessary to prove, either by the antibody titer (if a reliable assay is available) that the subjects has already been infected or to confirm that there is no acute infection by a negative PCR test for COVID-19 on a nasal or pharyngeal swab. (14) As a back-up option, thoracic CT scan has also been advocated as a method for identifying acutely infected patients. (3, 15) Patients should wear a surgical mask for their arrival at and stay in the hospital. On the day of HRM test, it is recommended that a screening interview is held to establish that the subject did not I develop any novel symptoms suggestive for COVID-19, that there was no contact with an infected subject, and that the subject's temperature is measured before entering the examination room. In case of new onset symptoms, exposure or a temperature rise, the examiner should consider postponement of the HRM. In addition, in order to prevent droplet infection and contact infection in the examination room, the examiner should consider arranging an environment where all subjects (including attendants) can keep a safe distance. (15) In a room with windows, if possible, open the windows on opposite or different sides simultaneously to encourage ventilation. During transnasal positioning and advancing of the HRM catheter, the patient should continue to wear a surgical mask over the mouth. Even with strict screening, false negatives can occur, (16) so as a general rule examiners must take standard precautions to prevent infection from COVID-19 when performing HRM tests. It is recommended to practice the maximum possible infection prevention according to the availability of resources such as personal protective equipment at each facility. Personnel should wear a mask with face shield (or goggles + mask), gloves, cap or hairnet, and a long-sleeved gown. Protective equipment should be replaced for each patient, and the examiner should thoroughly wash the hands after HRM tests. In addition, when cleaning after HRM tests, disinfection of catheters will be performed as usual with sufficient protective measures. Enveloped viruses such as coronaviruses are the least resistant to inactivation by disinfection. (17) In order to prevent contact infection, it is necessary to thoroughly disinfect not only the catheters but also the peripherals such as the used PC, table and bed. (3) When available, the use of a disposable probe cover sheath or condom is recommended to reduce the level of microbial exposure. It is also recommended that all catheters and probes are cleaned and disinfected after each procedure, with a chlorine dioxide based or comparable disinfectant. Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology Clinical impact of different cutoff values in high-resolution manometry systems on diagnosing esophageal motility disorders European Society for Neurogastroenterology and Motility (ESNM) recommendations for conducting gastrointestinal motility and function testing in the recovery phase of the COVID-19 pandemic A survey on the impact of the COVID-19 pandemic on motility and functional investigations in Europe and considerations for recommencing activities in the early recovery phase Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Technical aspects of clinical high-resolution manometry studies COVID-19 may transmit through aerosol Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission Clinical characteristics of coronavirus disease 2019 in China Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Longitudinal change of SARS-Cov2 antibodies in patients with COVID-19 The importance of chest CT scan in COVID-19 Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements) Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents The author, HS received scholarship funds for research from Daiichi-Sankyo, Otsuka Pharmaceutical Co., Ltd., MSD Co., Mylan EPD, Tanabe, and Takeda Pharmaceutical Co. and received service honoraria from Astellas Pharm, AstraZeneca K.K., EA Pharma Co., Ltd., Mylan EPD, Otsuka Pharm, Takeda Pharm, and Tsumura Co.